Advertisement

Reactions Weekly

, Volume 1747, Issue 1, pp 207–207 | Cite as

Nilotinib/prednisone/unspecified protein tyrosine kinase inhibitors

Tyrosine kinase inhibitor withdrawal syndromes and chronic myeloid leukaemia (CML) relapse: 2 case reports
Case report
  • 28 Downloads

Reference

  1. Diab M, et al. The spectrum of musculoskeletal symptoms in patients with chronic myeloid leukemia after stopping tyrosine kinase inhibitors. Leukemia Research 79: 1-2, Apr 2019. Available from: URL: http://doi.org/10.1016/j.leukres.2019.02.001 - USA

Copyright information

© Springer International Publishing AG 2019

Personalised recommendations